AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden
· Delayed Price · Currency is SEK 1.865
-0.030 (-1.58%)
Mar 9, 2026, 5:29 PM CET
AlzeCure Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 50.34 | 31.5 | 29.1 | 25.58 | 41.74 | Upgrade
|
| Cash & Short-Term Investments | 50.34 | 31.5 | 29.1 | 25.58 | 41.74 | Upgrade
|
| Cash Growth | 59.81% | 8.24% | 13.77% | -38.73% | -62.88% | Upgrade
|
| Accounts Receivable | - | 0.04 | - | - | - | Upgrade
|
| Other Receivables | 3.34 | 1.74 | 1.47 | 1.38 | 1.54 | Upgrade
|
| Receivables | 3.34 | 1.77 | 1.47 | 1.38 | 1.54 | Upgrade
|
| Prepaid Expenses | 1.2 | 0.94 | 1.04 | 0.55 | 0.92 | Upgrade
|
| Other Current Assets | 0.09 | - | - | - | - | Upgrade
|
| Total Current Assets | 54.96 | 34.21 | 31.61 | 27.51 | 44.2 | Upgrade
|
| Property, Plant & Equipment | 4.06 | 0.21 | 0.38 | 0.85 | 1.42 | Upgrade
|
| Other Intangible Assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Other Long-Term Assets | -0 | - | - | 42.46 | 0.01 | Upgrade
|
| Total Assets | 59.04 | 34.44 | 32 | 70.84 | 45.65 | Upgrade
|
| Accounts Payable | 4.16 | 2.69 | 2.69 | 4.85 | 5.97 | Upgrade
|
| Accrued Expenses | 6.67 | 5.25 | 4.95 | 5.18 | 6.38 | Upgrade
|
| Other Current Liabilities | 12.74 | 0.31 | 0.59 | 0.33 | 0.32 | Upgrade
|
| Total Current Liabilities | 23.56 | 8.25 | 8.23 | 10.35 | 12.67 | Upgrade
|
| Long-Term Leases | 2.56 | - | - | - | - | Upgrade
|
| Total Liabilities | 26.12 | 8.25 | 8.23 | 10.35 | 12.67 | Upgrade
|
| Common Stock | 2.87 | 2.21 | 1.55 | 1.27 | 0.94 | Upgrade
|
| Additional Paid-In Capital | 453.27 | 399.43 | 362.44 | 361.98 | 278.84 | Upgrade
|
| Retained Earnings | -423.22 | -375.45 | -340.22 | -303.05 | -246.81 | Upgrade
|
| Comprehensive Income & Other | - | - | - | 0.28 | - | Upgrade
|
| Shareholders' Equity | 32.92 | 26.19 | 23.77 | 60.48 | 32.97 | Upgrade
|
| Total Liabilities & Equity | 59.04 | 34.44 | 32 | 70.84 | 45.65 | Upgrade
|
| Total Debt | 2.56 | - | - | - | - | Upgrade
|
| Net Cash (Debt) | 47.78 | 31.5 | 29.1 | 25.58 | 41.74 | Upgrade
|
| Net Cash Growth | 51.68% | 8.24% | 13.77% | -38.73% | -62.88% | Upgrade
|
| Net Cash Per Share | 0.48 | 0.41 | 0.47 | 0.54 | 1.11 | Upgrade
|
| Filing Date Shares Outstanding | 114.91 | 88.3 | 62.09 | 62.09 | 37.77 | Upgrade
|
| Total Common Shares Outstanding | 114.91 | 88.3 | 62.09 | 62.09 | 37.77 | Upgrade
|
| Working Capital | 31.4 | 25.96 | 23.38 | 17.15 | 31.53 | Upgrade
|
| Book Value Per Share | 0.29 | 0.30 | 0.38 | 0.97 | 0.87 | Upgrade
|
| Tangible Book Value | 32.9 | 26.17 | 23.76 | 60.47 | 32.96 | Upgrade
|
| Tangible Book Value Per Share | 0.29 | 0.30 | 0.38 | 0.97 | 0.87 | Upgrade
|
| Machinery | - | 3.02 | 2.9 | 2.9 | 2.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.